4//SEC Filing
Favit-Van Pelt Antonella R. 4
Accession 0001140361-24-032528
CIK 0001610853other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:00 PM ET
Size
5.7 KB
Accession
0001140361-24-032528
Insider Transaction Report
Form 4
Favit-Van Pelt Antonella R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-07-02+277,000→ 277,000 totalExercise: $0.96Exp: 2034-07-01→ Class A Common Stock (277,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 62.5% of the options vested immediately upon grant, and the remaining options vest in a series of ten (10) successive equal quarterly installments on the last day of each quarter starting on September 30, 2024, subject to the Reporting Person's continued service through each applicable vesting period.
Documents
Issuer
HELIUS MEDICAL TECHNOLOGIES, INC.
CIK 0001610853
Entity typeother
Related Parties
1- filerCIK 0001871533
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:00 PM ET
- Size
- 5.7 KB